BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11507049)

  • 1. ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer.
    Rökman A; Ikonen T; Mononen N; Autio V; Matikainen MP; Koivisto PA; Tammela TL; Kallioniemi OP; Schleutker J
    Cancer Res; 2001 Aug; 61(16):6038-41. PubMed ID: 11507049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of HPC2/ELAC2 in hereditary prostate cancer.
    Wang L; McDonnell SK; Elkins DA; Slager SL; Christensen E; Marks AF; Cunningham JM; Peterson BJ; Jacobsen SJ; Cerhan JR; Blute ML; Schaid DJ; Thibodeau SN
    Cancer Res; 2001 Sep; 61(17):6494-9. PubMed ID: 11522646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men.
    Takahashi H; Lu W; Watanabe M; Katoh T; Furusato M; Tsukino H; Nakao H; Sudo A; Suzuki H; Akakura K; Ikemoto I; Asano K; Ito T; Wakui S; Muto T; Hano H
    Int J Cancer; 2003 Nov; 107(2):224-8. PubMed ID: 12949798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in the prostate cancer susceptibility gene HPC2/ELAC2 in multiplex families and healthy controls.
    Suarez BK; Gerhard DS; Lin J; Haberer B; Nguyen L; Kesterson NK; Catalona WJ
    Cancer Res; 2001 Jul; 61(13):4982-4. PubMed ID: 11431329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPC2/ELAC2 polymorphism associated with Japanese sporadic prostate cancer.
    Yokomizo A; Koga H; Kinukawa N; Tsukamoto T; Hirao Y; Akaza H; Mori M; Naito S
    Prostate; 2004 Nov; 61(3):248-52. PubMed ID: 15368467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germ-line alterations in MSR1 gene and prostate cancer risk.
    Seppälä EH; Ikonen T; Autio V; Rökman A; Mononen N; Matikainen MP; Tammela TL; Schleutker J
    Clin Cancer Res; 2003 Nov; 9(14):5252-6. PubMed ID: 14614006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity of the putative prostate cancer susceptibility gene HPC2/ELAC2 is uncommon in sporadic and familial prostate cancer.
    Wu YQ; Chen H; Rubin MA; Wojno KJ; Cooney KA
    Cancer Res; 2001 Dec; 61(24):8651-3. PubMed ID: 11751379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.
    Xu J; Zheng SL; Carpten JD; Nupponen NN; Robbins CM; Mestre J; Moses TY; Faith DA; Kelly BD; Isaacs SD; Wiley KE; Ewing CM; Bujnovszky P; Chang B; Bailey-Wilson J; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB
    Am J Hum Genet; 2001 Apr; 68(4):901-11. PubMed ID: 11254448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of common missense changes in ELAC2 ( HPC2) with prostate cancer in a Japanese case-control series.
    Fujiwara H; Emi M; Nagai H; Nishimura T; Konishi N; Kubota Y; Ichikawa T; Takahashi S; Shuin T; Habuchi T; Ogawa O; Inoue K; Skolnick MH; Swensen J; Camp NJ; Tavtigian SV
    J Hum Genet; 2002; 47(12):641-8. PubMed ID: 12522685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population.
    Suzuki K; Ohtake N; Nakata S; Takei T; Matsui H; Ono Y; Nakazato H; Hasumi M; Koike H; Ito K; Fukabori Y; Kurokawa K; Yamanaka H
    Anticancer Res; 2002; 22(6B):3507-11. PubMed ID: 12552947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancer.
    Nupponen NN; Wallén MJ; Ponciano D; Robbins CM; Tammela TL; Vessella RL; Carpten JD; Visakorpi T
    Genes Chromosomes Cancer; 2004 Feb; 39(2):119-25. PubMed ID: 14695991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ELAC2 and prostate cancer risk in Afro-Caribbeans of Tobago.
    Shea PR; Ferrell RE; Patrick AL; Kuller LH; Bunker CH
    Hum Genet; 2002 Oct; 111(4-5):398-400. PubMed ID: 12384782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The missense mutations in the candidate prostate cancer gene ELAC2 do not alter enzymatic properties of its product.
    Minagawa A; Takaku H; Takagi M; Nashimoto M
    Cancer Lett; 2005 May; 222(2):211-5. PubMed ID: 15863270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPC2/ELAC2 gene variants associated with incident prostate cancer.
    Adler D; Kanji N; Trpkov K; Fick G; Hughes RM
    J Hum Genet; 2003; 48(12):634-638. PubMed ID: 14625808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
    Sun J; Lange EM; Isaacs SD; Liu W; Wiley KE; Lange L; Gronberg H; Duggan D; Carpten JD; Walsh PC; Xu J; Chang BL; Isaacs WB; Zheng SL
    Prostate; 2008 Apr; 68(5):489-97. PubMed ID: 18213635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Study of Ser217Leu and Ala541Thr Polymorphism in the Men Afflicted with Prostate Cancer and in the Men being Suspicious of Prostate Cancer.
    Zahiri Z; Zahiri F
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1551-1557. PubMed ID: 32592348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the macrophage scavenger receptor 1 gene in Swedish hereditary and sporadic prostate cancer.
    Lindmark F; Jonsson BA; Bergh A; Stattin P; Zheng SL; Meyers DA; Xu J; Grönberg H
    Prostate; 2004 May; 59(2):132-40. PubMed ID: 15042613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truncating BRCA1 mutations are uncommon in a cohort of hereditary prostate cancer families with evidence of linkage to 17q markers.
    Zuhlke KA; Madeoy JJ; Beebe-Dimmer J; White KA; Griffin A; Lange EM; Gruber SB; Ostrander EA; Cooney KA
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):5975-80. PubMed ID: 15447980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer.
    Wiklund F; Jonsson BA; Brookes AJ; Strömqvist L; Adolfsson J; Emanuelsson M; Adami HO; Augustsson-Bälter K; Grönberg H
    Clin Cancer Res; 2004 Nov; 10(21):7150-6. PubMed ID: 15534086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.